Ainos expands Smell AI into breath analysis in National Taiwan University emergency medicine program

Ainos Inc

Ainos Inc

AIMD

0.00
  • Ainos launched a one-year research program with National Taiwan University starting July 1, 2026 to extend Smell AI into breath-based diagnostics.
  • Project targets rapid triage of emergency patients with dyspnea using an AI electronic nose to analyze exhaled volatile organic compounds.
  • Work aims to train and validate a deep-learning model to differentiate AECOPD from acute decompensated heart failure versus controls.
  • Program could build a proprietary dyspnea breath-print database to support future clinical deployments, though the workflow remains research-stage.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ainos Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606170800ACCESSWRNAPR_____1178463) on June 17, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.